Validation pour Ingenuity438

vers la météo de la validation par utilisateur

Ingenuity438

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 70 - PMID ?

Type 2 diabetes in humans is associated with upregulation of SP NODE RP1 [NODE] protein in serum .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                   +---------------------------COMP:V_PASS-N(in)--------------------------+    
                                   |                +----------------COMP:N-N(of)---------------+         |    
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+         |    
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+         |    
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+         |    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 1

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 2

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 3

      +---------------------------------------COMP:N-N(of)--------------------------------------+              
      +--------SUBJ:V_PASS-N-------+                             +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                             |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                             |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(of) (2,protein)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 4

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 5

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 6

                                                    +---------------------COMP:N-N(in)--------------------+    
                                                    +----------------COMP:N-N(of)---------------+         |    
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+         |    
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+         |    
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+         |    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,protein)
COMP:N-N(in) (upregulation,serum)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 7

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 8

      +---------------------------------------COMP:N-N(of)--------------------------------------+              
      +--------SUBJ:V_PASS-N-------+                             +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                             |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                             |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(of) (2,protein)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 9

                                                    +---------------------COMP:N-N(in)--------------------+    
                                                    +----------------COMP:N-N(of)---------------+         |    
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+         |    
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+         |    
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+         |    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
COMP:N-N(in) (upregulation,serum)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 10

                                                    +----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 11

      +----------------COMP:N-N(with)---------------+----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(with) (2,upregulation)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 12

      +---------------------------------------COMP:N-N(of)--------------------------------------+              
      +----------------COMP:N-N(with)---------------+                                           |              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+              
   |  |     |          |    |      |                |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(with) (2,upregulation)
COMP:N-N(of) (2,protein)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 13

      +----------------COMP:N-N(with)---------------+----------------COMP:N-N(of)---------------+              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(with) (2,upregulation)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 14

      +--------SUBJ:V_PASS-N-------+---------------------------COMP:V_PASS-N(in)--------------------------+    
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+         |    
      |     +----SUBJ:V-N---+      |       |        +----COMP:N-N(of)----+     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+     |       +MOD_ATT:+         |    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 15

                                   +---------------------------COMP:V_PASS-N(in)--------------------------+    
      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+         |    
      +-------OBJ:V-N-------+      |       |                             +-----MOD_ATT:N-ADJ----+         |    
      |     +----SUBJ:V-N---+      |       |                             |     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+COMP:N-N(of)+       |     |       +MOD_ATT:+         |    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 16

                                   +---------------------------COMP:V_PASS-N(in)--------------------------+    
                                   |       +-----------------------OBJ:V-N----------------------+         |    
      +--------SUBJ:V_PASS-N-------+       |        +-----------COMP:N-N(of)-----------+        |         |    
      +-------OBJ:V-N-------+      |       |        |            +----MOD_ATT:N-ADJ----+        |         |    
      |     +----SUBJ:V-N---+      |       |        |            |       +MOD_ATT:N-ADJ+        |         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     +MOD_ATT+        |         |    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,[__NODE__])
MOD_ATT:N-ADJ ([__NODE__],__SP__)
MOD_ATT:N-ADJ ([__NODE__],__NODE__)
MOD_ATT:N-N ([__NODE__],RP1)

Analyse 17

                                                    +---------------------COMP:N-N(in)--------------------+    
      +----------------COMP:N-N(with)---------------+----------------COMP:N-N(of)---------------+         |    
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+         |    
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+         |    
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+         |    
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+         |    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(with) (2,upregulation)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:N-N(of) (upregulation,protein)
COMP:N-N(in) (upregulation,serum)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 18

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +----COMP:N-N(of)----+     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+     |       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 19

      +---------------------------------------COMP:N-N(of)--------------------------------------+              
      +----------------COMP:N-N(with)---------------+                                           |              
      +--------SUBJ:V_PASS-N-------+                |            +---------MOD_ATT:N-ADJ--------+              
      +-------OBJ:V-N-------+      |                |            |       +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |                |            |       |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |                |            |       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |                |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(with) (2,upregulation)
COMP:N-N(of) (2,protein)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 20

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |                             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |       |                             |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+COMP:N-N(of)+       |     |       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 21

                                           +-----------------------OBJ:V-N----------------------+              
      +--------SUBJ:V_PASS-N-------+       |        +-----------COMP:N-N(of)-----------+        |              
      +-------OBJ:V-N-------+      |       |        |            +----MOD_ATT:N-ADJ----+        |              
      |     +----SUBJ:V-N---+      |       |        |            |       +MOD_ATT:N-ADJ+        |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     +MOD_ATT+        |              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,[__NODE__])
MOD_ATT:N-ADJ ([__NODE__],__SP__)
MOD_ATT:N-ADJ ([__NODE__],__NODE__)
MOD_ATT:N-N ([__NODE__],RP1)

Analyse 22

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +----COMP:N-N(of)----+     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |       |        |            +MOD_ATT+     |       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 23

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |                             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |       |                             |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |       |        +COMP:N-N(of)+       |     |       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 24

                                           +-----------------------OBJ:V-N----------------------+              
      +--------SUBJ:V_PASS-N-------+       |        +-----------COMP:N-N(of)-----------+        |              
      +-------OBJ:V-N-------+      |       |        |            +----MOD_ATT:N-ADJ----+        |              
      |     +----SUBJ:V-N---+      |       |        |            |       +MOD_ATT:N-ADJ+        |              
   +OB+     +COMP:N-N(i+    |      |       |        |            |       |     +MOD_ATT+        |              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,[__NODE__])
MOD_ATT:N-ADJ ([__NODE__],__SP__)
MOD_ATT:N-ADJ ([__NODE__],__NODE__)
MOD_ATT:N-N ([__NODE__],RP1)

Analyse 25

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +----COMP:N-N(of)----+     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 26

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |                             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |       |                             |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+COMP:N-N(of)+       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 27

                                           +-----------------------OBJ:V-N----------------------+              
      +--------SUBJ:V_PASS-N-------+       |        +-----------COMP:N-N(of)-----------+        |              
      +-------OBJ:V-N-------+      |       |        |            +----MOD_ATT:N-ADJ----+        |              
      |     +----SUBJ:V-N---+      |       |        |            |       +MOD_ATT:N-ADJ+        |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       |     +MOD_ATT+        +COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,[__NODE__])
MOD_ATT:N-ADJ ([__NODE__],__SP__)
MOD_ATT:N-ADJ ([__NODE__],__NODE__)
MOD_ATT:N-N ([__NODE__],RP1)
COMP:N-N(in) (protein,serum)

Analyse 28

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +----COMP:N-N(of)----+     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |       |        |            +MOD_ATT+     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 29

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |                             +-----MOD_ATT:N-ADJ----+              
      |     +----SUBJ:V-N---+      |       |                             |     +---MOD_ATT:N-N--+              
   +OB+     +COMP:N-N(i+    |      |       |        +COMP:N-N(of)+       |     |       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,RP1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 30

                                           +-----------------------OBJ:V-N----------------------+              
      +--------SUBJ:V_PASS-N-------+       |        +-----------COMP:N-N(of)-----------+        |              
      +-------OBJ:V-N-------+      |       |        |            +----MOD_ATT:N-ADJ----+        |              
      |     +----SUBJ:V-N---+      |       |        |            |       +MOD_ATT:N-ADJ+        |              
   +OB+     +COMP:N-N(i+    |      |       |        |            |       |     +MOD_ATT+        +COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,[__NODE__])
MOD_ATT:N-ADJ ([__NODE__],__SP__)
MOD_ATT:N-ADJ ([__NODE__],__NODE__)
MOD_ATT:N-N ([__NODE__],RP1)
COMP:N-N(in) (protein,serum)

Analyse 31

                                   +---------------------------COMP:V_PASS-N(in)--------------------------+    
      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+         |    
      +-------OBJ:V-N-------+      |       |        +-------COMP:N-N(of)-------+                |         |    
      |     +----SUBJ:V-N---+      |       |        |            +MOD_ATT:N-ADJ+                |         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       +MOD_A+       +MOD_ATT:+         |    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (RP1,__SP__)
MOD_ATT:N-ADJ (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 32

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |        +-------COMP:N-N(of)-------+                |              
      |     +----SUBJ:V-N---+      |       |        |            +MOD_ATT:N-ADJ+                |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       +MOD_A+       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (RP1,__SP__)
MOD_ATT:N-ADJ (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 33

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |        +-------COMP:N-N(of)-------+                |              
      |     +----SUBJ:V-N---+      |       |        |            +MOD_ATT:N-ADJ+                |              
   +OB+     +COMP:N-N(i+    |      |       |        |            |       +MOD_A+       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (RP1,__SP__)
MOD_ATT:N-ADJ (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 34

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |        +-------COMP:N-N(of)-------+                |              
      |     +----SUBJ:V-N---+      |       |        |            +MOD_ATT:N-ADJ+                |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            |       +MOD_A+       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (RP1,__SP__)
MOD_ATT:N-ADJ (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 35

      +--------SUBJ:V_PASS-N-------+       +-----------------------OBJ:V-N----------------------+              
      +-------OBJ:V-N-------+      |       |        +-------COMP:N-N(of)-------+                |              
      |     +----SUBJ:V-N---+      |       |        |            +MOD_ATT:N-ADJ+                |              
   +OB+     +COMP:N-N(i+    |      |       |        |            |       +MOD_A+       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (RP1,__SP__)
MOD_ATT:N-ADJ (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 36

      +--------SUBJ:V_PASS-N-------+---------------------------COMP:V_PASS-N(in)--------------------------+    
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+         |    
      |     +----SUBJ:V-N---+      |       |        +-------COMP:N-N(of)-------+                |         |    
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+MOD_A+       +MOD_ATT:+         |    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
COMP:V_PASS-N(in) (associate,serum)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 37

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +-------COMP:N-N(of)-------+                |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+MOD_A+       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 38

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +-------COMP:N-N(of)-------+                |              
   +OB+     +COMP:N-N(i+    |      |       |        |            +MOD_ATT+MOD_A+       +MOD_ATT:+              
   |  |     |          |    |      |       |        |            |       |     |       |        |              
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])

Analyse 39

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +-------COMP:N-N(of)-------+                |              
   +OB+     +COMP:N-N(i+    |      +COMP:V_PASS-N(wi+            +MOD_ATT+MOD_A+       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
COMP:V_PASS-N(with) (associate,upregulation)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)

Analyse 40

      +--------SUBJ:V_PASS-N-------+                                                                           
      +-------OBJ:V-N-------+      |       +-----------------------OBJ:V-N----------------------+              
      |     +----SUBJ:V-N---+      |       |        +-------COMP:N-N(of)-------+                |              
   +OB+     +COMP:N-N(i+    |      |       |        |            +MOD_ATT+MOD_A+       +MOD_ATT:+COMP:N-N(+    
   |  |     |          |    |      |       |        |            |       |     |       |        |         |    
 Type 2 diabetes in humans is associated with upregulation of __SP__ __NODE__ RP1 [__NODE__] protein in serum .
OBJ:V-N (type,2)
COMP:N-N(in) (diabetes,human)
OBJ:V-N (be,2)
SUBJ:V-N (be,diabetes)
SUBJ:V_PASS-N (associate,2)
OBJ:V-N (with,protein)
COMP:N-N(of) (upregulation,RP1)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (RP1,__NODE__)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,serum)